Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
Open-market buys, last 90 days
$82,244
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$82,244. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-01 Sohn Catherine A. Director Grant or award · Stock Options (option to buy) +48,800 48,800
2026-01-05 Sohn Catherine A. Director Purchase +500 $4.24 $2K 1,500
2025-09-25 Sohn Catherine A. Director Grant or award · Stock Options (option to buy) +48,800 48,800
2025-03-17 Sohn Catherine A. Director Purchase +1,000 $5.78 $6K 1,000
2025-02-06 Sohn Catherine A. Director Grant or award · Stock Options (option to buy) +18,600 18,600
2024-09-26 Sohn Catherine A. Director Grant or award · Stock Options (option to buy) +34,900 34,900
2023-09-28 Sohn Catherine A. Director Grant or award · Stock Options (option to buy) +26,100 26,100
2023-03-23 Sohn Catherine A. Director Grant or award · Stock Options (option to buy) +47,000 47,000

Page 1 of 1 · 8 trades